Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
$26.50−0.82 (-2.98%)
Close on Nov 20, 2026Market cap $1.28BP/E –Yield –
Nanobiotix free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -€33.96M. The highest annual figure on record is -€12.80M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€33.96M | – |
| FY2024 | Dec 31, 2024 | -€20.40M | – |
| FY2023 | Dec 31, 2023 | -€12.80M | – |
| FY2022 | Dec 31, 2022 | -€37.20M | – |
| FY2021 | Dec 31, 2021 | -€30.10M | – |
| FY2020 | Dec 31, 2020 | -€27.63M | – |
| FY2019 | Dec 31, 2019 | -€42.26M | – |
| FY2018 | Dec 31, 2018 | -€26.40M | – |
See a number that looks wrong?